Canada Markets closed
  • S&P/TSX

    20,621.39
    -436.81 (-2.07%)
     
  • S&P 500

    4,397.94
    -84.79 (-1.89%)
     
  • DOW

    34,265.37
    -450.03 (-1.30%)
     
  • CAD/USD

    0.7947
    -0.0052 (-0.6517%)
     
  • CRUDE OIL

    84.83
    -0.72 (-0.84%)
     
  • BTC-CAD

    44,425.25
    -1,525.25 (-3.32%)
     
  • CMC Crypto 200

    870.86
    +628.18 (+258.85%)
     
  • GOLD FUTURES

    1,836.10
    -6.50 (-0.35%)
     
  • RUSSELL 2000

    1,987.92
    -36.12 (-1.78%)
     
  • 10-Yr Bond

    1.7470
    -0.0860 (-4.69%)
     
  • NASDAQ

    13,768.92
    -385.08 (-2.72%)
     
  • VOLATILITY

    28.85
    +3.26 (+12.74%)
     
  • FTSE

    7,494.13
    -90.88 (-1.20%)
     
  • NIKKEI 225

    27,522.26
    -250.64 (-0.90%)
     
  • CAD/EUR

    0.7001
    -0.0066 (-0.93%)
     

Global Enteral Collagen Peptide Protein Market Report 2021-2030: Poor Demand in Underdeveloped Countries & High Growth Potential in Emerging Markets

·3 min read

Dublin, Dec. 02, 2021 (GLOBE NEWSWIRE) -- The "Enteral Collagen Peptide Protein Market by Form, Age Group and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

The global enteral collagen peptide protein market was valued at $14,586 thousand in 2020, and is projected to reach $25,811 thousand by 2030, registering a CAGR of 7.2% from 2021-2030.

Collagen peptide protein is a protein derived from animal collagen. Collagen peptides are a versatile source of protein and an important element of healthy nutrition. Their nutritional and physiological properties promote the health of bones & joints and prevent osteoarthritis.

Enteral collagen peptide protein is a rich source of healthy nutrients that is prescribed to patients, who are unable to consume sufficient nutrients orally but whose gastrointestinal function help in digestion and absorption.

Enteral collagen peptide protein products are used when a patient is unable to eat due to some illness, has swallowing difficulties, or has undergone surgery that may interfere with the normal eating process. In this process, collagen peptides protein are administered directly into the stomach, duodenum, or jejunum of a patient via enteral pumps and enteral feeding tubes.

Enteral collagen peptide protein supplements are prescribed to patients suffering from chronic diseases such as malnutrition, osteoarthritis, and osteoporosis. Generally, collagen peptides protein enteral feeding is used in hospitals & clinics, home care, and nursing home.

The growth of the global enteral collagen peptide protein market is majorly driven by rise in prevalence of chronic illness such osteoarthritis and cardiovascular diseases and increase in application of enteral collagen peptide proteins in the healthcare sector.

Furthermore, surge in geriatric population and favorable government initiatives to promote healthy diet among population. However, poor demand and lack of awareness of enteral collagen peptide protein products in underdeveloped countries hamper the market growth. Conversely, high growth potential in untapped emerging economies is expected to provide lucrative opportunities for the growth of the global market.

MARKET DYNAMICS

Drivers

  • Increase in prevalence of chronic disorders

  • Surge in geriatric population

  • Rise in number of malnutrition cases

Restraint

  • Poor demand in underdeveloped countries

Opportunity

  • High growth potential in emerging markets

COVID-19 impact analysis on enteral collagen peptide protein market

Key Players

  • Abbott laboratories

  • Danone S.A (Nutricia)

  • Dermarites Industries LLC

  • Medtronic, Inc

  • Medline Industries, Inc

  • Global Health Products, Inc.

  • OP2 labs, LLC

  • Fresenius Kabi AG

  • Gelita AG

  • Weishardt Holding SA

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

  • It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

  • A comprehensive analysis of four regions is provided to determine the existing opportunities.

  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Form

  • Powder

  • Liquid

By Age-Group

  • Adults (Above 18)

  • Pediatrics (Below 18)

By End User

  • Hospitals & clinics

  • Homecare

  • Nursing Home

By Region

  • North America

  • U.S.

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • Asia-Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • LAMEA

  • Brazil

  • Saudi Arabia

  • South Africa

  • Rest of LAMEA

For more information about this report visit https://www.researchandmarkets.com/r/jy0h29

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting